{
  "symbol": "ACCD",
  "company_name": "Accolade Inc",
  "ir_website": "https://ir.accolade.com/",
  "structured_data": [
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Accolade To Present at Upcoming Investor Conferences",
          "url": "https://ir.accolade.com/news-releases/news-release-details/accolade-present-upcoming-investor-conferences-3",
          "content": "[Skip to content](#lfg-main-content)\n\n[![accolade logo](/sites/g/files/knoqqb76241/themes/site/nir_pid3576/dist/images/accolade_logotype_nd_color.png)](https://www.accolade.com/?utm_source=accolade_IR&utm_medium=brand_logo)\n\n[![accolade logo](/sites/g/files/knoqqb76241/themes/site/nir_pid3576/dist/images/accolade_logotype_nd_color.png)](https://www.accolade.com/?utm_source=accolade_IR&utm_medium=brand_logo)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/press-releases)\n  * [ESG/Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Leadership](https://www.accolade.com/leadership?utm_source=accolade_IR&utm_medium=leadership_header)\n    * [Board of Directors](https://www.accolade.com/leadership#board-of-directors?utm_source=accolade_IR&utm_medium=board_of_directors_header)\n    * [Medical Advisory Board](https://www.accolade.com/leadership#medical-advisory-board?utm_source=accolade_IR&utm_medium=medical_advisory_header)\n  * [Events and Presentations](/events-and-presentations/events)\n    * [Events](/events-and-presentations/events)\n    * [Presentations](/events-and-presentations/presentations)\n  * [Shareholder Services](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/contact-ir)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Historic Price Lookup](/stock-information/historic-price-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n  * [SEC Filings](/financial-information/sec-filings)\n\n\n\n  * #  Press Release Details \n\n\n\n\n# \n\nAccolade To Present at Upcoming Investor Conferences\n\nNovember 13, 2024 \n\n[PDF Version](/node/12056/pdf)\n\nSEATTLE, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the following upcoming investor events. A webcast will be available at ir.accolade.com and a replay will be available for 90 days.\n\n  * Stephens Annual Investment Conference | NASH2024 in Nashville on Wednesday, November 20 at 9:00 am CT\n  * CG MedTech, Diagnostics and Digital Health & Services Forum in New York on Thursday, November 21. (1x1 meetings, no webcast)\n  * Piper Sandler 36th Annual Healthcare Conference in New York on Thursday, December 5 at 10:00 am ET.\n\n\n\n**About Accolade, Inc.**\n\nAccolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accoladeâ€™s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit [accolade.com](https://www.globenewswire.com/Tracker?data=hGspThTG1eNnCOv1xj6O-KHnBO4xgxwXAtBTnJsnfUSsDEnYcO7b1a7zENOn1Rg7LaOW-dvoqqIMG-K6mnQwgw==). Follow us on [LinkedIn](https://www.globenewswire.com/Tracker?data=HnwJn6F5Ol_TDs97xb0PYE5_yyc35Q2JD94CCvO7e9hqcFN1og46VRnF6B9kZrAL-Iec3uyAQTJI6XG0mxJNYpRfZs10Wcznb25V-byamCE=), [Twitter](https://www.globenewswire.com/Tracker?data=B7jJZNZ2LuruuPmeSdpZdZtuts90In61T8eQChNAKL349ori_oftZ0DXEmDlJzXzK2g7vCIITE_R2ks0WYOciQ==)[,](https://www.globenewswire.com/Tracker?data=7CFj6bT0ooqZBzlt36gmTM57J-jABHEqowVpyxH-1ZPK87AuqLWdnMS7af05MzoVa4pXLlvVGgLywXpfoAOHYA==) [Instagram](https://www.globenewswire.com/Tracker?data=yTV5WcPyFJDLa0u6Re0L2uThubmAP4QymPs0U9vWshQccgFgeOnGy7P5WjodlXOHyDDOtIHxBYeosfjMCpVlQPYtEHMNrTXXtK30qgMSDaDSi3k12abgF6ndwC78pOuP) and [Facebook](https://www.globenewswire.com/Tracker?data=9u_oXBCM9tYJQDZzjXe2xcbm-hKpcKqtxV3vrs4X97a5HsOfO6GmMdPixVf0paJjN9E5sGzAdLFRPXwoz0f9ybW1z_Y1pxF2MYw4xEIeZP4=).\n\n**Investor Contact:**\n\nTodd Friedman, Investor Relations, [IR@accolade.com](https://www.globenewswire.com/Tracker?data=QLKumzyAYFtUl8QAzfPKiyWkiPzhDHAIZwYm3sNZIynoZR_FwBGeKVi7VVx6yt7v3o639TA0c7tImTmneWB5zA==)\n\n![](https://ml.globenewswire.com/media/NGNiOTViOGItNTY3OC00Mjc4LThjODYtNTFlZmI2YjAxY2YwLTEyMDYwNjk=/tiny/Accolade-Inc-.png)\n\n[](/shareholder-services/rss-feeds \"RSS Feeds\")\n\n[](/contact-ir \"Contact IR\")\n\n[](/shareholder-services/email-alerts \"Email Alerts\")\n"
        },
        {
          "title": "Download PDF version of Accolade To Present at Upcoming Investor Conferences",
          "url": "https://ir.accolade.com/node/12056/pdf",
          "content": "\n"
        }
      ]
    },
    {
      "section_name": "SEC Filings",
      "links": [
        {
          "title": "0001127602-24-028080.pdf",
          "url": "https://ir.accolade.com/static-files/5fc29a23-a09e-41d3-a3ba-c01841adb80b",
          "content": "\n"
        },
        {
          "title": "View details page of Form 4 in row 2",
          "url": "https://ir.accolade.com/sec-filings/sec-filing/4/0001127602-24-028080",
          "content": "[Skip to content](#lfg-main-content)\n\n[![accolade logo](/sites/g/files/knoqqb76241/themes/site/nir_pid3576/dist/images/accolade_logotype_nd_color.png)](https://www.accolade.com/?utm_source=accolade_IR&utm_medium=brand_logo)\n\n[![accolade logo](/sites/g/files/knoqqb76241/themes/site/nir_pid3576/dist/images/accolade_logotype_nd_color.png)](https://www.accolade.com/?utm_source=accolade_IR&utm_medium=brand_logo)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/press-releases)\n  * [ESG/Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Leadership](https://www.accolade.com/leadership?utm_source=accolade_IR&utm_medium=leadership_header)\n    * [Board of Directors](https://www.accolade.com/leadership#board-of-directors?utm_source=accolade_IR&utm_medium=board_of_directors_header)\n    * [Medical Advisory Board](https://www.accolade.com/leadership#medical-advisory-board?utm_source=accolade_IR&utm_medium=medical_advisory_header)\n  * [Events and Presentations](/events-and-presentations/events)\n    * [Events](/events-and-presentations/events)\n    * [Presentations](/events-and-presentations/presentations)\n  * [Shareholder Services](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/contact-ir)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Historic Price Lookup](/stock-information/historic-price-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n  * [SEC Filings](/financial-information/sec-filings)\n\n\n\n  * #  SEC Filing Details\n\n\n\n\n## Document Details\n\nForm\n\n[ 4 ](/node/12131/html)\n\nFiling Date\n\nNov 26, 2024\n\nDocument Date\n\nNov 25, 2024\n\nForm Description\n\nStatement of changes in beneficial ownership of securities\n\nFiling Group\n\n3,4,5\n\nCompany\n\nAccolade\n\nIssuer\n\nAccolade, Inc.\n\nFiler\n\nCAVANAUGH ROBERT N\n\n## Filing Formats\n\n[View HTML](/node/12131/html)\n\n[Download PDF](/static-files/5fc29a23-a09e-41d3-a3ba-c01841adb80b \"0001127602-24-028080.pdf\")\n\n[Download DOC](/static-files/8a530754-e3e9-47dd-a309-5aa7516c7606 \"0001127602-24-028080.rtf\")\n\n[Download XLS](/static-files/e75632e3-5f21-4cf0-9788-8d05d75711f2 \"0001127602-24-028080.xls\")\n\n[](/shareholder-services/rss-feeds \"RSS Feeds\")\n\n[](/contact-ir \"Contact IR\")\n\n[](/shareholder-services/email-alerts \"Email Alerts\")\n"
        },
        {
          "title": "0001127602-24-028082.pdf",
          "url": "https://ir.accolade.com/static-files/ce923364-059d-4f1f-8876-42b993e2f670",
          "content": "\n"
        },
        {
          "title": "View details page of Form 4 in row 3",
          "url": "https://ir.accolade.com/sec-filings/sec-filing/4/0001127602-24-028082",
          "content": "[Skip to content](#lfg-main-content)\n\n[![accolade logo](/sites/g/files/knoqqb76241/themes/site/nir_pid3576/dist/images/accolade_logotype_nd_color.png)](https://www.accolade.com/?utm_source=accolade_IR&utm_medium=brand_logo)\n\n[![accolade logo](/sites/g/files/knoqqb76241/themes/site/nir_pid3576/dist/images/accolade_logotype_nd_color.png)](https://www.accolade.com/?utm_source=accolade_IR&utm_medium=brand_logo)\n\n  * [Home](/ \"Main Investor Relations Page\")\n  * [Press Releases](/press-releases)\n  * [ESG/Governance](/corporate-governance/governance-overview)\n    * [Governance Overview](/corporate-governance/governance-overview)\n    * [Leadership](https://www.accolade.com/leadership?utm_source=accolade_IR&utm_medium=leadership_header)\n    * [Board of Directors](https://www.accolade.com/leadership#board-of-directors?utm_source=accolade_IR&utm_medium=board_of_directors_header)\n    * [Medical Advisory Board](https://www.accolade.com/leadership#medical-advisory-board?utm_source=accolade_IR&utm_medium=medical_advisory_header)\n  * [Events and Presentations](/events-and-presentations/events)\n    * [Events](/events-and-presentations/events)\n    * [Presentations](/events-and-presentations/presentations)\n  * [Shareholder Services](/shareholder-services/investor-faqs)\n    * [Investor FAQs](/shareholder-services/investor-faqs)\n    * [Email Alerts](/shareholder-services/email-alerts)\n    * [Contact IR](/contact-ir)\n  * [Stock Information](/stock-information/stock-quote-chart)\n    * [Stock Quote & Chart](/stock-information/stock-quote-chart)\n    * [Historic Price Lookup](/stock-information/historic-price-lookup)\n    * [Investment Calculator](/stock-information/investment-calculator)\n  * [SEC Filings](/financial-information/sec-filings)\n\n\n\n  * #  SEC Filing Details\n\n\n\n\n## Document Details\n\nForm\n\n[ 4 ](/node/12136/html)\n\nFiling Date\n\nNov 26, 2024\n\nDocument Date\n\nNov 25, 2024\n\nForm Description\n\nStatement of changes in beneficial ownership of securities\n\nFiling Group\n\n3,4,5\n\nCompany\n\nAccolade\n\nIssuer\n\nAccolade, Inc.\n\nFiler\n\nESKEW RICHARD\n\n## Filing Formats\n\n[View HTML](/node/12136/html)\n\n[Download PDF](/static-files/ce923364-059d-4f1f-8876-42b993e2f670 \"0001127602-24-028082.pdf\")\n\n[Download DOC](/static-files/8584b06c-07af-41b3-bbbe-e35501ace09d \"0001127602-24-028082.rtf\")\n\n[Download XLS](/static-files/24234064-52b3-45f0-ac03-eac8fbdaf895 \"0001127602-24-028082.xls\")\n\n[](/shareholder-services/rss-feeds \"RSS Feeds\")\n\n[](/contact-ir \"Contact IR\")\n\n[](/shareholder-services/email-alerts \"Email Alerts\")\n"
        }
      ]
    }
  ]
}